Daubert v. Merrell Dow Pharmaceuticals

Also found in: Wikipedia.
A lawsuit by brought by J. Daubert, who was born with limb-reduction defects, alleging that the cause of his disability was Bendectin, produced by Merrell Dow Pharmaceuticals
References in periodicals archive ?
107) Interpretation of the Federal Rules of Evidence standard for expert testimony was altered again in 1993 when the Supreme Court heard Daubert v.
The admissibility of scientific evidence has been affected by a Supreme Court decision made in Daubert v.
2) Addressing these concerns, the Supreme Court set the standard for the admissibility of expert testimony in the 1993 case of Daubert v.
Beginning with the first of those decisions, known as Daubert v.
They argue that the goals of the rules have not been well-served by judicial decisions that have sought to implement the Supreme Court's ruling in Daubert v.
Affirming, the Sixth Circuit determined in an opinion by Judge Oliver that both of Clark's expert witnesses demonstrated that their scientific testimony was sufficiently reliable under standards set in Daubert v.
Following a two-year effort by defense lawyers to hold fingerprint analysis to standards set by the Supreme Court in the 1993 Daubert v.
Seventy years later, a unanimous Supreme Court rejected the "general acceptance" test as the sole criteria for determining the admissibility of scientific expert evidence in Daubert v.
Court of Appeals' Ninth Circuit, Pasadena, and had been one of the judges to hear Daubert v.
IDM)--an operating partner of West--the DAUBERT Citator database (DAUBERT), containing annotations to all cases, federal and state, citing Daubert v.
Instead, in 1993, the Supreme Court's decision in Daubert v.